GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the effector-binding domain of S. aureus ccpe

Analyse Crystal structure of the effector-binding domain of S. aureus ccpe in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4QBA
Type
protein
Length
400 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Lysr family regulatory protein
UniProt
Q6GBF8
Ligands
CL
Pockets
4 · best druggability 0.71

Structure

x-ray diffraction · 2 distinct chains · 38% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALysr family regulatory proteinprotein20440% helix, 33% strandQ6GBF8
BLysr family regulatory proteinprotein19637% helix, 33% strandQ6GBF8

Ligands and binding sites

  • CL · Chloride ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14650.710.8155CL
22290.530.7724empty
31210.400.7521empty
41010.360.7523empty

Interfaces

1 interface between chains.

  • A–B · 1226 Ų buried · 18 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 17 modified (engineered).

Compared structures

  • 4QBA · Crystal structure of the effector-binding domain of S. aureus CcpE · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.